Steroid Injections for Trigger Finger
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if steroid injections for trigger finger cause less pain when administered from the back of the hand rather than the front. Trigger finger, which causes finger pain and locking, is often treated with a steroid injection. Researchers seek to compare the pain levels of injections from both sides of the hand and assess if the numbing effect remains consistent. Individuals diagnosed with trigger finger and planning to receive a steroid injection may be suitable candidates for this trial. As an unphased trial, it offers participants the chance to contribute to research that could enhance treatment comfort for future patients.
Do I need to stop my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What prior data suggests that this technique is safe for reducing pain in trigger finger injections?
Research has shown that both the palmar (front) and dorsal (back) approaches for steroid injections to treat trigger finger are generally safe. Studies indicate no harmful effects or complications arise from either method. The dorsal approach, involving steroid injection from the back of the hand, is reported to be less painful and just as effective as the usual palmar method. This dorsal method appears to be a good option for reducing pain during the injection. Overall, these findings suggest that both methods are well-tolerated and safe for patients.12345
Why are researchers excited about this trial?
Researchers are excited about these treatments for trigger finger because they explore different injection approaches that could potentially enhance patient comfort and treatment effectiveness. The dorsal webspace approach is unique as it targets the flexor tendon sheath from the back of the hand, which might reduce pain associated with the needle passing through the sensitive palmar skin. Additionally, both methods use a combination of triamcinolone and lidocaine, which could offer rapid relief of symptoms by combining anti-inflammatory and numbing effects. This trial aims to determine if these approaches can offer better outcomes compared to the traditional palmar approach typically used in current treatments.
What evidence suggests that this trial's treatments could be effective for reducing injection-related pain in trigger finger?
This trial will compare two methods of steroid injections for treating trigger finger. The Palmar Approach, which participants may receive, involves injecting the steroid mixture into the palm. Studies have shown that this method can ease symptoms for up to 10 years in some people. The Dorsal Webspace Approach, another method under study, involves injecting at the back of the hand and is considered equally effective. Some evidence suggests that this back-of-the-hand method might cause less pain. Both methods aim to reduce the pain and finger locking caused by trigger finger by calming the swelling around the finger tendons.12345
Who Is on the Research Team?
Kevin Zuo, MD, MASc
Principal Investigator
University Health Network, Toronto
Are You a Good Fit for This Trial?
This trial is for individuals with trigger finger, a condition where a finger gets stuck in a bent position. Participants should be those who haven't had relief from other treatments and are suitable candidates for steroid injections.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive corticosteroid injections using either the palmar or dorsal approach
Follow-up
Participants are monitored for pain and sensory changes post-injection
What Are the Treatments Tested in This Trial?
Interventions
- Dorsal webspace combined corticosteroid and anesthetic injection
- Palmar combined corticosteroid and anesthetic injection
Dorsal webspace combined corticosteroid and anesthetic injection is already approved in United States, European Union for the following indications:
- Trigger finger
- Trigger finger
Find a Clinic Near You
Who Is Running the Clinical Trial?
Kevin Zuo
Lead Sponsor